Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment.

Veritti D, Sarao V, Lanzetta P.

J Ophthalmol. 2019 Jan 10;2019:3120960. doi: 10.1155/2019/3120960. eCollection 2019.

2.

Living with Geographic Atrophy: An Ethnographic Study.

Sivaprasad S, Tschosik EA, Guymer RH, Kapre A, Suñer IJ, Joussen AM, Lanzetta P, Ferrara D.

Ophthalmol Ther. 2019 Mar;8(1):115-124. doi: 10.1007/s40123-019-0160-3. Epub 2019 Jan 31.

3.

A 5-Year-Old Case of Choroidal Neovascularization in Enhanced S-Cone Syndrome Treated with Ranibizumab.

Bertoli F, Pignatto S, Rizzetto F, Lanzetta P.

Case Rep Ophthalmol. 2018 Dec 21;9(3):510-515. doi: 10.1159/000495743. eCollection 2018 Sep-Dec.

4.

Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia.

Nangia V, Jonas JB, George R, Lingam V, Ellwein L, Cicinelli MV, Das A, Flaxman SR, Keeffe JE, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester AJ, Tahhan N, Taylor HR, Wong TY, Bourne RRA; Vision Loss Expert Group of the Global Burden of Disease Study.

Br J Ophthalmol. 2018 Nov 8. pii: bjophthalmol-2018-312292. doi: 10.1136/bjophthalmol-2018-312292. [Epub ahead of print]

PMID:
30409914
5.

Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections.

Leasher JL, Braithwaite T, Furtado JM, Flaxman SR, Lansingh VC, Silva JC, Resnikoff S, Taylor HR, Bourne RRA; Vision Loss Expert Group of the Global Burden of Disease Study.

Br J Ophthalmol. 2018 Sep 12. pii: bjophthalmol-2017-311746. doi: 10.1136/bjophthalmol-2017-311746. [Epub ahead of print]

PMID:
30209083
6.

Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery.

Sarao V, Veritti D, Maurutto E, Rassu N, Borrelli E, Loewenstein A, Sadda S, Lanzetta P.

Expert Opin Pharmacother. 2018 Oct;19(14):1551-1563. doi: 10.1080/14656566.2018.1516206. Epub 2018 Sep 5. Review.

PMID:
30185069
7.

The role of OCT-A in retinal disease management.

Rodríguez FJ, Staurenghi G, Gale R; Vision Academy Steering Committee.

Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2019-2026. doi: 10.1007/s00417-018-4109-3. Epub 2018 Sep 3. Review.

8.

TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing.

Veritti D, Sarao V, Missiroli F, Ricci F, Lanzetta P.

Retina. 2018 Aug 29. doi: 10.1097/IAE.0000000000002299. [Epub ahead of print]

PMID:
30161093
9.

A Comparison between the Compass Fundus Perimeter and the Humphrey Field Analyzer.

Montesano G, Bryan SR, Crabb DP, Fogagnolo P, Oddone F, McKendrick AM, Turpin A, Lanzetta P, Perdicchi A, Johnson CA, Garway-Heath DF, Brusini P, Rossetti LM.

Ophthalmology. 2019 Feb;126(2):242-251. doi: 10.1016/j.ophtha.2018.08.010. Epub 2018 Aug 14.

PMID:
30114416
10.

Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review.

Menchini F, Toneatto G, Miele A, Donati S, Lanzetta P, Virgili G.

Eye (Lond). 2018 Sep;32(9):1423-1431. doi: 10.1038/s41433-018-0138-8. Epub 2018 Jun 11.

PMID:
29891901
11.

Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy.

Borrelli E, Nittala MG, Abdelfattah NS, Lei J, Hariri AH, Shi Y, Fan W, Cozzi M, Sarao V, Lanzetta P, Staurenghi G, Sadda SR.

Br J Ophthalmol. 2018 Jun 5. pii: bjophthalmol-2018-311849. doi: 10.1136/bjophthalmol-2018-311849. [Epub ahead of print]

12.

Posterior lamellar reconstruction: a comprehensive review of the literature.

Fin A, De Biasio F, Lanzetta P, Mura S, Tarantini A, Parodi PC.

Orbit. 2019 Feb;38(1):51-66. doi: 10.1080/01676830.2018.1474236. Epub 2018 May 21.

PMID:
29781746
13.

Predictors of visual outcomes in patients with neovascular age-related macular degeneration treated with anti-vascular endothelial growth factor therapy: post hoc analysis of the VIEW studies.

Lanzetta P, Cruess AF, Cohen SY, Slakter JS, Katz T, Sowade O, Zeitz O, Ahlers C, Mitchell P.

Acta Ophthalmol. 2018 Dec;96(8):e911-e918. doi: 10.1111/aos.13751. Epub 2018 Apr 16.

PMID:
29659183
14.

Aflibercept in the Treatment of Diabetic Macular Edema: A Review and Consensus Paper.

Avitabile T, Azzolini C, Bandello F, Boscia F, De Falco S, Fornasari D, Lanzetta P, Mastropasqua L, Midena E, Ricci F, Staurenghi G, Varano M.

Eur J Ophthalmol. 2017 Nov 8;27(6):627-639. doi: 10.5301/ejo.5001053. Review.

PMID:
29077188
15.

Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.

Flaxman SR, Bourne RRA, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR; Vision Loss Expert Group of the Global Burden of Disease Study.

Lancet Glob Health. 2017 Dec;5(12):e1221-e1234. doi: 10.1016/S2214-109X(17)30393-5. Epub 2017 Oct 11. Review.

16.

Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome.

Al-Khersan H, Hariprasad SM, Chhablani J; Dex Implant Study Group.

Am J Ophthalmol. 2017 Dec;184:121-128. doi: 10.1016/j.ajo.2017.10.004. Epub 2017 Oct 13.

PMID:
29032109
17.

Green emission fluorophores in eyes with atrophic age-related macular degeneration: a colour fundus autofluorescence pilot study.

Borrelli E, Lei J, Balasubramanian S, Uji A, Cozzi M, Sarao V, Lanzetta P, Staurenghi G, Sadda SR.

Br J Ophthalmol. 2018 Jun;102(6):827-832. doi: 10.1136/bjophthalmol-2017-310881. Epub 2017 Sep 25.

PMID:
28972030
18.

Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis.

Bourne RRA, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, Pesudovs K, Resnikoff S, Silvester A, Stevens GA, Tahhan N, Wong TY, Taylor HR; Vision Loss Expert Group.

Lancet Glob Health. 2017 Sep;5(9):e888-e897. doi: 10.1016/S2214-109X(17)30293-0. Epub 2017 Aug 2. Review.

19.

Fluocinolone acetonide for the treatment of diabetic macular edema.

Veritti D, Sarao V, Diplotti L, Samassa F, Lanzetta P.

Expert Opin Pharmacother. 2017 Oct;18(14):1507-1516. doi: 10.1080/14656566.2017.1363182. Epub 2017 Aug 9. Review.

PMID:
28764565
20.

EFFICACY AND SAFETY OF RANIBIZUMAB FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION DUE TO UNCOMMON CAUSE: Twelve-Month Results of the MINERVA Study.

Lai TYY, Staurenghi G, Lanzetta P, Holz FG, Melissa Liew SH, Desset-Brethes S, Staines H, Hykin PG; MINERVA study group.

Retina. 2018 Aug;38(8):1464-1477. doi: 10.1097/IAE.0000000000001744.

Supplemental Content

Loading ...
Support Center